Baseline characteristics of participants
anxiety disorder, Anxiety, anxiety, caseness, Insomnia, depression, Depression
DISORDER, DISORDER
Between 10 December 2020 and 16 September 2021 (with final 3-month follow-up assessment completed on 18 February 2022), 174 participants were enrolled into the trial. The majority of participants were female (83.9%), and were university educated (71.3%). In terms of caseness of psychological problems, 85.1% met the cut-off for probable depression (2.3% for severe depression), 79.3% for probable anxiety disorder (1.7% for severe anxiety), 32.0% for generalised anxiety disorder. There were 87 participants randomised to the intervention and 87 to EUC. Participants in the intervention and EUC did not differ at baseline on any sociodemographic characteristics or baseline psychopathology measures (Study flow diagram. EUC, enhanced usual care.Demographic and participant characteristicsModerate/Severe depression=HADS-Depression Scale score ≥15. Moderate/Severe anxiety=HADS-Anxiety Scale score ≥15. Generalised anxiety disorder=GAD-7 score ≥15. Insomnia=Sleep Impairment Index score ≥10.GAD-7, Generalised Anxiety Disorder Scale; HADS, Hospital Anxiety and Depression Scale.